Skip to content

Clinical observation and mechanism of autism spectrum disorder

Clinical observation and mechanism of autism spectrum disorder

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077762
Enrollment
Unknown
Registered
2023-11-18
Start date
2023-11-18
Completion date
Unknown
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism spectrum disorders

Interventions

Acupuncture group:Acupuncture

Sponsors

Dongfang Hospital Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) ASD has been diagnosed by a specialist; (2) age 4-22 years old; (3) patients who volunteered to participate in the study and could adhere to acupuncture treatment for 12 weeks; (4) patients voluntarily agreed not to add other therapies during the study period; (5) no adjustment in the use of psychotropic drugs or other autism related drugs within 12 weeks before enrollment; (6) Informed consent has been obtained and informed consent has been signed voluntarily.

Exclusion criteria

Exclusion criteria: (1) patients with serious physical diseases such as cardiovascular, renal, liver and hematopoietic system; (2) severe congenital or acquired limb deformities on physical examination; (3) skull absence and/or dysraphism due to trauma or congenital factors; (4) severe impairment or loss of vision or hearing; (5) patients with other severe neurological disorders.

Design outcomes

Primary

MeasureTime frame
Childhood Autism Rating Scale;Pittsburgh sleep quality index;

Secondary

MeasureTime frame
Autism Behavior Checklist;Social Responsiveness Scale;functional magnetic resonance;

Countries

China

Contacts

Public Contactzheng ruwen

Dongfang Hospital Beijing University of Chinese Medicine

Zrw123@sina.com+86 189 1058 5316

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026